CD4 and myeloid sarcoma: As our in vitro experiments with fresh human PBMCs may mimic what occurs in an inflammatory environment, we determined whether circulating CD4+ T cells express c-Met in patients with inflammatory diseases, such as multiple sclerosis (MS) or cancer (i.e., malignant melanoma, MM).